Boston Scientific To Pay Cordis $716M In Stent War

Law360, New York (September 29, 2009, 6:15 PM EDT) -- Following more than a decade of litigation, Boston Scientific Corp. has agreed to fork over a whopping $716 million to Johnson & Johnson unit Cordis Corp. to settle more than a dozen lawsuits over stent technology.

Boston Scientific on Tuesday revealed the settlement of the long-running dispute with Cordis, which includes the Palmaz-Nir suit, as well as a few other cardiology-related cases relating to patents in the Ding, Kastenhofer, Palmaz and Fontirroche patent families.

"We are pleased we have been able to significantly reduce the amount...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.